Developer docs
API playgroundTry for free, no card

Search company profiles

ONCare Alliance

Full company profile

uuid0008xmk

Namestring
ONCare Alliance
Legal namestring
ONCare Alliance, LLC
Company typeenum
Private
Founded yearint
2024
Descriptiontext

ONCare Alliance is a national network of independent community oncology practices, formed in February 2024 through the merger of the National Cancer Care Alliance (NCCA) and the Quality Cancer Care Alliance (QCCA). The company serves 30 member practices located across more than 20 U.S. states, providing centralized tools, clinical trial access, advocacy, education and training, and a proprietary shared data engine that aggregates treatment data across the network to support real-world evidence generation and population health analysis. Representative research outputs include a 300-patient retrospective study of HER2-low metastatic breast cancer patients receiving T-DXd in community oncology settings and an AYVAKIT tolerability/persistence analysis from real-world ONCare data.

The core technology is a proprietary shared data engine that ingests and analyzes treatment, trend, and outcome data from member practices, supplemented in January 2025 by a multi-omics database and biobank partnership with Ovation.io aimed at accelerating biomarker discovery. ONCare distributes its offering through a layer of affiliate organizations that handle clinical trial operations (Exigent, P1 Trials), drug purchasing and pricing (Athena Oncology, Prism TPO), operational efficiency (Clarion), and training (Oncology College), along with the Cancer Safety Net Foundation for community-level support.

Revenue is generated through membership fees paid by independent oncology practices joining the network, structured as a recurring subscription. The go-to-motion is direct practice recruitment: ONCare invites mid-market independent oncology practices to join while preserving their clinical autonomy, and member practices gain access to the shared data engine, research collaborations, peer support, and group purchasing benefits. The organization is privately held, headquartered at 1624 S I St, Tacoma, Washington, and has not disclosed any external funding rounds; leadership is provided by a board of practicing oncologists led by Co-Chairs Dr. Sibel Blau (President/CEO) and Dr. Barbara McAneny (Chief Officer of Advocacy and Government Affairs).

Short descriptiontext

ONCare Alliance is a national network of 30 independent community oncology practices across 20+ U.S. states, formed in February 2024 through the NCCA and QCCA merger, offering members a proprietary shared data engine, clinical trial access, group purchasing, and practice support services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTacoma, United States
HQ citystring
Tacoma
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
community oncology network, oncology practice support, clinical trial network, cancer care services, real-world evidence data
Industry2 codes
PRIMARYHLAKAFAB
Medical Oncology
SECONDARYHLAFABAI
Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
NAICS code1 code
  • Other Ambulatory Health Care Services6219
SIC code1 code
  • Services-Health Services8000
Product category
Community oncology network services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Member Practice Network Fees
TypeSubscription Recurring
Description

Independent oncology practices pay membership fees to join the ONCare Alliance network, gaining access to centralized tools, research collaboration, data insights, practice enhancement strategies, group purchasing benefits, and peer support.

oncarealliance.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ONCare Alliance operates a national membership-based network of 30 independent community oncology practices, providing centralized tools, shared proprietary data infrastructure, collaborative research and clinical trial access, group purchasing, business and management training, and peer support services. Member practices pay recurring fees to access the collective network benefits while retaining clinical autonomy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • T-DXd tolerability demonstrated with 15% toxicity-related discontinuation rate in real-world community setting (similar to 16.2% in DESTINY-Breast04 trial)
+1 more record
Product overview1 text field

ONCare Alliance is a platform/network of fiercely independent community oncology practices offering collaborative access to research, education, data-based projects, patient support services, and practice enhancement strategies. The core offering is the ONCare Alliance Network, which includes 30 independent oncology practices across the United States, supported by a proprietary shared data engine for analyzing treatments and trends. The network is supplemented by affiliated products including Exigent Research Network for clinical trial support, Oncology College for business and management training, P1 Trials for Phase 1 clinical trial access, Prism TPO for drug pricing transparency, Athena Oncology for coordinated drug purchasing, Cancer Safety Net Foundation for patient support, and Clarion for operational efficiency solutions.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-01-07
Description

ONCare Alliance and Ovation.io partnered to create a multi-omics database and biobank to accelerate biomarker discovery in oncology. This partnership enables real-world evidence collection and advanced genomic data analysis across the network of member practices.

2National Cancer Care Alliance (NCCA)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-01
Description

NCCA merged with Quality Cancer Care Alliance (QCCA) to form ONCare Alliance in February 2024. NCCA was one of the founding organizations of the merged entity.

prnewswire.com
3Quality Cancer Care Alliance (QCCA)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-01
Description

QCCA merged with National Cancer Care Alliance (NCCA) to form ONCare Alliance in February 2024. QCCA was one of the founding organizations of the merged entity.

prnewswire.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Exigent provides centralized support for clinical trials and proprietary data insight, democratizing access to cancer research starting at the point of care. An affiliate organization offering benefits to ONCare Alliance members.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Training delivered by industry leaders available in-person, via virtual meetings and on-demand. Provides essential business, management and legal skills to ensure long-term viability of member practices.

6Cancer Safety Net Foundation
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Funding local organizations making impact on social determinants of health in communities. Raises funds nationally through donations from donors, foundations, and corporations.

oncarealliance.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Empowers members with solutions that boost operational and clinical efficiency, provide financial resources, and allow focus on delivering exceptional cancer care within communities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Group of independent community oncology practices synchronizing, centralizing, and managing drug purchasing efforts for better long-term viability of member practices.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Offers independent medical practices upfront, transparent, and trustworthy drug pricing by eliminating over 80% of traditional pricing components such as retrospective distribution rebates.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Empowers community-based oncology clinics to participate in groundbreaking Phase 1 clinical trials, providing patients access to investigational new therapies close to home.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

A large independent community oncology practice and clinical research site. Operates with similar autonomy and trial/research emphasis as member practices of ONCare Alliance.

2ASCO (American Society of Clinical Oncology)
TypeOthers
Description

The leading professional society for oncologists, serving overlapping audiences (medical oncologists) and overlapping interests in research, education, and clinical-trial access relevant to ONCare's member practices.

TypeDirect peer
Description

A physician-led community oncology network offering practice management, revenue cycle, and clinical trial access to independent practices. Directly comparable service bundle and member profile to ONCare Alliance.

TypeDirect peer
Description

A platform partnership formed by independent oncology practices to share services, technology, and research. Functions almost identically to ONCare Alliance as a network enabling independent practice scale.

TypeDirect peer
Description

One of the largest independent community oncology practices in the U.S., with research and clinical-trial infrastructure analogous to what ONCare Alliance aggregates across its member network.

TypeDirect peer
Description

The largest U.S. community oncology practice network, backed by McKesson, providing centralized infrastructure, data, and pharma services to member practices. Directly comparable to ONCare Alliance in mission and operating model, though with greater scale and capital backing.

7McKesson (US Oncology Research)
TypeBroad incumbent
Description

Parent of US Oncology Network with deep pharma services and real-world evidence capabilities across community oncology, a much larger incumbent against which ONCare Alliance competes for member practices and pharma data deals.

TypeBroad incumbent
Description

A major healthcare distributor whose specialty oncology solutions serve community oncology practices, overlapping with ONCare's drug-pricing and distribution-focused affiliates such as Prism TPO and Athena Oncology.

TypeOthers
Description

Technology partner that co-developed ONCare's multi-omics database and biobank, providing the real-world evidence infrastructure layer that underpins ONCare's research product.

TypeOthers
Description

A non-profit advocacy organization that represents independent community oncology practices and is closely aligned with ONCare Alliance's mission to preserve independent practice models.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers31 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ONCare Alliance

Community oncology network servicesoncarealliance.com

ONCare Alliance is a national network of 30 independent community oncology practices across 20+ U.S. states, formed in February 2024 through the NCCA and QCCA merger, offering members a proprietary shared data engine, clinical trial access, group purchasing, and practice support services.

What ONCare Alliance does

ONCare Alliance is a national network of independent community oncology practices, formed in February 2024 through the merger of the National Cancer Care Alliance (NCCA) and the Quality Cancer Care Alliance (QCCA). The company serves 30 member practices located across more than 20 U.S. states, providing centralized tools, clinical trial access, advocacy, education and training, and a proprietary shared data engine that aggregates treatment data across the network to support real-world evidence generation and population health analysis. Representative research outputs include a 300-patient retrospective study of HER2-low metastatic breast cancer patients receiving T-DXd in community oncology settings and an AYVAKIT tolerability/persistence analysis from real-world ONCare data.

The core technology is a proprietary shared data engine that ingests and analyzes treatment, trend, and outcome data from member practices, supplemented in January 2025 by a multi-omics database and biobank partnership with Ovation.io aimed at accelerating biomarker discovery. ONCare distributes its offering through a layer of affiliate organizations that handle clinical trial operations (Exigent, P1 Trials), drug purchasing and pricing (Athena Oncology, Prism TPO), operational efficiency (Clarion), and training (Oncology College), along with the Cancer Safety Net Foundation for community-level support.

Revenue is generated through membership fees paid by independent oncology practices joining the network, structured as a recurring subscription. The go-to-motion is direct practice recruitment: ONCare invites mid-market independent oncology practices to join while preserving their clinical autonomy, and member practices gain access to the shared data engine, research collaborations, peer support, and group purchasing benefits. The organization is privately held, headquartered at 1624 S I St, Tacoma, Washington, and has not disclosed any external funding rounds; leadership is provided by a board of practicing oncologists led by Co-Chairs Dr. Sibel Blau (President/CEO) and Dr. Barbara McAneny (Chief Officer of Advocacy and Government Affairs).

ONCare Alliance firmographics

Firmographics
Name
ONCare Alliance
Legal name
ONCare Alliance, LLC
Website
https://oncarealliance.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
ONCare Alliance is a national network of 30 independent community oncology practices across 20+ U.S. states, formed in February 2024 through the NCCA and QCCA merger, offering members a proprietary shared data engine, clinical trial access, group purchasing, and practice support services.
Ownership category
akta.pro rank

ONCare Alliance industry classification

Industry
Product category
Community oncology network services
NAICS
Other Ambulatory Health Care Services (6219)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAKAFAB
Medical Oncology
SECONDARYHLAFABAI
Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers

Keywords

  • Community oncology network
  • Oncology practice support
  • Clinical trial network
  • Cancer care services
  • Real-world evidence data

Where ONCare Alliance is headquartered

Location

Headquarters

HQ city
Tacoma
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ONCare Alliance business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Member Practice Network Fees: Independent oncology practices pay membership fees to join the ONCare Alliance network, gaining access to centralized tools, research collaboration, data insights, practice enhancement strategies, group purchasing benefits, and peer support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

ONCare Alliance product offering

Product offering

Core offering

ONCare Alliance operates a national membership-based network of 30 independent community oncology practices, providing centralized tools, shared proprietary data infrastructure, collaborative research and clinical trial access, group purchasing, business and management training, and peer support services. Member practices pay recurring fees to access the collective network benefits while retaining clinical autonomy.

Product overview

ONCare Alliance is a platform/network of fiercely independent community oncology practices offering collaborative access to research, education, data-based projects, patient support services, and practice enhancement strategies. The core offering is the ONCare Alliance Network, which includes 30 independent oncology practices across the United States, supported by a proprietary shared data engine for analyzing treatments and trends. The network is supplemented by affiliated products including Exigent Research Network for clinical trial support, Oncology College for business and management training, P1 Trials for Phase 1 clinical trial access, Prism TPO for drug pricing transparency, Athena Oncology for coordinated drug purchasing, Cancer Safety Net Foundation for patient support, and Clarion for operational efficiency solutions.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • T-DXd tolerability demonstrated with 15% toxicity-related discontinuation rate in real-world community setting (similar to 16.2% in DESTINY-Breast04 trial)
  • +1 more outcomes

Companies that use ONCare Alliance

Customer profile

Named customers31 records

Segments1 record

Ideal customer profiles1 record

ONCare Alliance technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

ONCare Alliance partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • Ovation.iocoreTechnology or Integration · 7 January 2025ONCare Alliance and Ovation.io partnered to create a multi-omics database and biobank to accelerate biomarker discovery in oncology. This partnership enables real-world evidence collection and advanced genomic data analysis across the network of member practices.
  • National Cancer Care Alliance (NCCA)coreStrategic or Co-development Partner · 1 February 2024NCCA merged with Quality Cancer Care Alliance (QCCA) to form ONCare Alliance in February 2024. NCCA was one of the founding organizations of the merged entity.
  • Quality Cancer Care Alliance (QCCA)coreStrategic or Co-development Partner · 1 February 2024QCCA merged with National Cancer Care Alliance (NCCA) to form ONCare Alliance in February 2024. QCCA was one of the founding organizations of the merged entity.
  • ExigentcoreStrategic or Co-development PartnerExigent provides centralized support for clinical trials and proprietary data insight, democratizing access to cancer research starting at the point of care. An affiliate organization offering benefits to ONCare Alliance members.
  • Oncology CollegecoreStrategic or Co-development PartnerTraining delivered by industry leaders available in-person, via virtual meetings and on-demand. Provides essential business, management and legal skills to ensure long-term viability of member practices.
  • Cancer Safety Net FoundationminorStrategic or Co-development PartnerFunding local organizations making impact on social determinants of health in communities. Raises funds nationally through donations from donors, foundations, and corporations.
  • ClarionminorStrategic or Co-development PartnerEmpowers members with solutions that boost operational and clinical efficiency, provide financial resources, and allow focus on delivering exceptional cancer care within communities.
  • Athena OncologycoreStrategic or Co-development PartnerGroup of independent community oncology practices synchronizing, centralizing, and managing drug purchasing efforts for better long-term viability of member practices.
  • Prism TPOminorStrategic or Co-development PartnerOffers independent medical practices upfront, transparent, and trustworthy drug pricing by eliminating over 80% of traditional pricing components such as retrospective distribution rebates.
  • P1 TrialscoreStrategic or Co-development PartnerEmpowers community-based oncology clinics to participate in groundbreaking Phase 1 clinical trials, providing patients access to investigational new therapies close to home.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

ONCare Alliance competitors and assessment

Company assessment

Direct peers

  • Tennessee Oncology: A large independent community oncology practice and clinical research site. Operates with similar autonomy and trial/research emphasis as member practices of ONCare Alliance.
  • American Oncology Network: A physician-led community oncology network offering practice management, revenue cycle, and clinical trial access to independent practices. Directly comparable service bundle and member profile to ONCare Alliance.
  • OneOncology: A platform partnership formed by independent oncology practices to share services, technology, and research. Functions almost identically to ONCare Alliance as a network enabling independent practice scale.
  • Florida Cancer Specialists & Research Institute: One of the largest independent community oncology practices in the U.S., with research and clinical-trial infrastructure analogous to what ONCare Alliance aggregates across its member network.
  • US Oncology Network: The largest U.S. community oncology practice network, backed by McKesson, providing centralized infrastructure, data, and pharma services to member practices. Directly comparable to ONCare Alliance in mission and operating model, though with greater scale and capital backing.

Others

  • ASCO (American Society of Clinical Oncology): The leading professional society for oncologists, serving overlapping audiences (medical oncologists) and overlapping interests in research, education, and clinical-trial access relevant to ONCare's member practices.
  • Ovation.io: Technology partner that co-developed ONCare's multi-omics database and biobank, providing the real-world evidence infrastructure layer that underpins ONCare's research product.
  • Community Oncology Alliance: A non-profit advocacy organization that represents independent community oncology practices and is closely aligned with ONCare Alliance's mission to preserve independent practice models.

Broad incumbents

  • McKesson (US Oncology Research): Parent of US Oncology Network with deep pharma services and real-world evidence capabilities across community oncology, a much larger incumbent against which ONCare Alliance competes for member practices and pharma data deals.
  • Cardinal Health Specialty Solutions (Oncology): A major healthcare distributor whose specialty oncology solutions serve community oncology practices, overlapping with ONCare's drug-pricing and distribution-focused affiliates such as Prism TPO and Athena Oncology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

ONCare Alliance social profiles

Digital presence

ONCare Alliance compliance and trust

Trust signal

Compliance1 record

ONCare Alliance financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ONCare Alliance leadership team

Management profile

Number of profiles

Profiles5 records

ONCare Alliance funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ONCare Alliance M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ONCare Alliance

What does ONCare Alliance do?

ONCare Alliance operates a national membership-based network of 30 independent community oncology practices, providing centralized tools, shared proprietary data infrastructure, collaborative research and clinical trial access, group purchasing, business and management training, and peer support services. Member practices pay recurring fees to access the collective network benefits while retaining clinical autonomy.

Is ONCare Alliance a public or private company?

ONCare Alliance is a private company. It is classified as unknown and is currently operating.

When was ONCare Alliance founded?

ONCare Alliance was founded in 2024. It employs 11 to 50 people.

Where is ONCare Alliance based?

ONCare Alliance is headquartered in Tacoma, United States, in the North America region.

How does ONCare Alliance make money?

One revenue line is on record: member Practice Network Fees.

Who are ONCare Alliance's main competitors?

Direct peers on record are Tennessee Oncology, American Oncology Network, OneOncology, Florida Cancer Specialists & Research Institute and US Oncology Network. Others are ASCO (American Society of Clinical Oncology), Ovation.io and Community Oncology Alliance. Broad incumbents are McKesson (US Oncology Research) and Cardinal Health Specialty Solutions (Oncology).

Does ONCare Alliance have an API?

No public API is recorded for ONCare Alliance.

What industry is ONCare Alliance in?

ONCare Alliance's product category is Community oncology network services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 6219 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MorningstarKlarity and ONCare Alliance Announce Vendor PartnershipKlarity and ONCare Alliance have announced a vendor partnership to expand access to Klarity's radiation therapy positioning and immobilization solutions for member practices. The collaboration aims to enhance treatment quality, operational efficiency, and patient-centered care within the community oncology network.PR NewswireKlarity and ONCare Alliance Announce Vendor PartnershipKlarity and ONCare Alliance announced a vendor partnership on July 22, 2026, expanding access to radiation therapy positioning and immobilization solutions for ONCare Alliance member practices. Clarion, ONCare Alliance's subsidiary buying group, facilitated the agreement, enabling member clinics to access Klarity's product portfolio, educational resources, and dedicated support. The partnership aims to enhance treatment quality, operational efficiency, and patient care across the community oncology network.PR NewswireONCare Alliance Announces Addition of Premier Cancer Care & Infusion Center to Its NetworkPremier Cancer Care & Infusion Center from Fresno, California has joined the ONCare Alliance network of independent oncology practices. The partnership brings the network to thirty practices nationwide and represents a shared commitment to preserving independent community oncology care models. ONCare Alliance was established in February 2024 through the merger of the National Cancer Care Alliance and the Quality Cancer Care Alliance.Oncology Nursing NewsReal-World Data Show T-DXd Tolerability in HER2-Low mBC in Community SettingA retrospective real-world study of 300 patients with HER2-low metastatic breast cancer receiving T-DXd in community oncology settings showed similar toxicity-related discontinuation rates (15%) to the DESTINY-Breast04 phase 3 trial (16.2%), despite higher disease burdens in the real-world cohort. The study, conducted via data curated through the ONCare Alliance and presented at the 43rd Annual Miami Breast Cancer Conference, demonstrated T-DXd's feasibility in community settings outside controlled trial environments.PR NewswireONCare Alliance Welcomes East Texas Hematology Oncology to Its Expanding NetworkONCare Alliance announced the addition of East Texas Hematology Oncology, a cancer care provider based in Lufkin, Texas, to its expanding national network of independent oncology practices. The 40-year-old practice joins to gain access to clinical trials, data analytics, and operational support amid a rapidly evolving oncology landscape. With this addition, ONCare Alliance expands to 32 practices and over 850 providers across the nation.OvationONCare Alliance and Ovation.io Partner to Create a Multi-Omics Database and Biobank to Accelerate Biomarker Discovery in OncologyONCare Alliance and Ovation.io have partnered to create a multi-omics database and biobank aimed at accelerating biomarker discovery in oncology. The collaboration combines real-world clinical EMR data from 32 independent oncology practices with research-grade multi-omics data to support precision medicine. This initiative focuses on collecting serial samples from breast cancer and non-small cell lung cancer patients to generate longitudinal datasets for drug discovery.Business Wire BlogONCare Alliance and Ovation.io Partner to Create a Multi-Omics Database and Biobank to Accelerate Biomarker Discovery in OncologyONCare Alliance and Ovation.io partnered to create a multi-omics database and biobank for oncology biomarker discovery, combining real-world EMR data with research-grade omics data. The collaboration involves 12 cancer centers and two breast cancer and one lung cancer cohorts, with expansion planned.PharmiWeb.comSteady Growth for ONCare Alliance With the Addition of Two New Practices in Nebraska and IllinoisONCare Alliance, formed by merging NCCA and QCCA, added Cancer Partners of Nebraska and Hope and Healing. The alliance now has 32 practices and 472 providers, with a mission to empower independent practices and foster innovation.American Medical Association4 ways this oncology merger empowers private practice physiciansThe National Cancer Care Alliance and Quality Cancer Care Alliance merged in February 2024 to form the ONCare Alliance, a network of 32 private oncology practices serving 3.1 million patients. The alliance aims to help independent practices compete with corporate systems by consolidating purchasing, sharing clinical trial data, and addressing social drivers of health through its foundation. Additionally, the organization launched Oncology College to provide training on practice management and sustainability for physicians.